Advertisement

GMED

Globus Medical, Inc.

Healthcare · USD

Set alert

Price alert · GMED

All alert types
78.05 USD -4.86 -5.86%
As of Oct 30, 2026 Extended hours 78.05 0.00%
Bid
77.99 × 200
Ask
78.11 × 500
77.77 Day range 80.84
60.39 52-week range 96.82
YTD
-10.61%
1 year
+28.54%
Open
80.80
Prev close
82.91
Mkt cap
10.48B
Vol
1.68M
Avg vol
1.40M
EPS
3.90
P/E
20.01
Div yield
0.00%
More statistics
Low
77.77
High
80.84
Forward P/E
14.49
Beta
0.96
Short ratio
5.17
Inst. own
94.12%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
77.77
200-d avg
83.57
1y target
100.92

5D chart

Chart tools
Interval
GMED five-day price chart78.579.380.281.182.0Oct 22Oct 23Oct 26Oct 27Oct 28

Key statistics

Market cap
10.48B
Enterprise value
10.65B
Trailing P/E
20.02
Forward P/E
14.49
PEG ratio
1.49
Price / sales
3.33
Price / book
2.20
EPS (TTM)
3.90
Beta
0.96
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
17.03%
Revenue (TTM)
3.14B
Revenue growth
5.90%
Free cash flow
554.19M
Total cash
595.14M
Total debt
111.91M
Return on equity
11.81%
Shares outstanding
111.83M
Short % of float
7.38%
50-day average
77.77
200-day average
83.57

Analyst view

Consensus: buy

Buy
Price target (mean) 100.92 +29.3% upside
Target (low)
84.00
Target (mean)
100.92
Target (high)
125.00
Ratings (0m) 14 10 buy · 4 hold · 0 sell
  • Strong buy3
  • Buy7
  • Hold4
  • Sell0
  • Strong sell0

Next earnings

Nov 5, 2026

Expected Nov 5, 2026. Consensus EPS estimate 1.20.

Earnings history

Financials — quick view

All financials
GMED Revenue — quarterly 789.61M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
GMED Net income — quarterly 151.57M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
GMED EPS — quarterly 1.12
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

GMED recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 5, 2026Sep 30, 20261.20———
Aug 6, 2026Jun 30, 20261.101.34+0.24+21.82%
May 7, 2026Mar 31, 20260.921.12+0.20+21.74%
Feb 24, 2026Dec 31, 20251.061.28+0.22+20.75%
Nov 6, 2025Sep 30, 20250.7811.18+0.40+51.09%
Aug 7, 2025Jun 30, 20250.760.86+0.10+13.16%

Upgrades / downgrades

GMED analyst upgrades and downgrades
DateFirmActionFromTo
Oct 1, 2026RBC CapitalmainOutperformOutperform
Aug 7, 2026Wells FargomainOverweightOverweight
Jul 28, 2026UBSinit—Neutral
Jul 16, 2026Truist SecuritiesmainBuyBuy
Jul 13, 2026RBC CapitalmainOutperformOutperform
Jul 9, 2026BMO Capitalinit—Outperform

About Globus Medical, Inc.

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on GMED — it syncs with the Stock Master app.

Insider holders

GMED insider holders
InsiderRelationLatest transactionDateShares held
DAVIDAR DAVID DDirectorStock GiftJul 26, 2026673,642
KLINE KYLEChief Financial OfficerSaleJan 7, 20260
LEMAITRE DANIELDirectorSaleNov 21, 20240
NORWALK LESLIE VDirectorSaleJan 7, 202610,419
PAUL DAVID COfficer, Director and Beneficial OwnerConversion of Exercise of derivative securityDec 7, 202560,417
PFEIL KEITH W.Chief Operating OfficerSaleJan 9, 20250

Institution ownership

GMED institution ownership
Holder% heldSharesValueReported
Blackrock Inc.8.05%10,806,724843.90MJun 29, 2026
Jupiter Topco LLC6.11%8,200,423640.37MJun 29, 2026
Vanguard Capital Management LLC3.80%5,107,532398.85MJun 29, 2026
Vanguard Portfolio Management LLC3.72%4,994,385390.01MJun 29, 2026
Invesco Ltd.3.21%4,309,771336.55MJun 29, 2026
Kayne Anderson Rudnick Investment Management LLC3.19%4,279,730334.20MJun 29, 2026

Fund ownership

GMED fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Mid-Cap ETF2.97%3,983,485311.07MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.68%3,595,564280.78MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund1.93%2,597,815202.86MJun 29, 2026
JANUS INVESTMENT FUND-Janus Henderson Enterprise Fund1.64%2,207,141172.36MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund1.11%1,496,500116.86MJun 29, 2026
J.P. Morgan Fleming Mutual Fd. Group, Inc.-JPMorgan Mid Cap Value Fd.1.10%1,475,978115.26MJun 29, 2026
Advertisement